Legal & General Group
TARS icon

Legal & General Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Legal & General Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
27,743
+2,847
+11% +$182K ﹤0.01% 2011
2026
Q1 		$1.75M Sell
24,896
-6,200
-20% -$433K ﹤0.01% 1963
2025
Q4 		$2.55M Sell
31,096
-215
-0.7% -$16.1K ﹤0.01% 1877
2025
Q3 		$1.86M Sell
31,311
-4,115
-12% -$203K ﹤0.01% 2012
2025
Q2 		$1.44M Buy
35,426
+7,832
+28% +$352K ﹤0.01% 2106
2025
Q1 		$1.42M Buy
27,594
+999
+4% +$49.4K ﹤0.01% 2056
2024
Q4 		$1.47M Buy
26,595
+2,016
+8% +$91.6K ﹤0.01% 2107
2024
Q3 		$808K Buy
24,579
+93
+0.4% +$2.61K ﹤0.01% 2303
2024
Q2 		$666K Buy
24,486
+1,655
+7% +$55.6K ﹤0.01% 2328
2024
Q1 		$830K Hold
22,831
– – ﹤0.01% 2256
2023
Q4 		$462K Buy
22,831
+2,279
+11% +$38.1K ﹤0.01% 2487
2023
Q3 		$365K Buy
20,552
+7,471
+57% +$132K ﹤0.01% 2553
2023
Q2 		$236K Buy
13,081
+5,736
+78% +$91.2K ﹤0.01% 2701
2023
Q1 		$92.3K Buy
7,345
+442
+6% +$6.46K ﹤0.01% 2789
2022
Q4 		$101K Buy
6,903
+4,463
+183% +$73.9K ﹤0.01% 2815
2022
Q3 		$41K Buy
2,440
+909
+59% +$14.4K ﹤0.01% 3020
2022
Q2 		$22K Buy
1,531
+663
+76% +$9.95K ﹤0.01% 3205
2022
Q1 		$15K Buy
868
+50
+6% +$928 ﹤0.01% 3304
2021
Q4 		$19K Hold
818
– – ﹤0.01% 3295
2021
Q3 		$18K Hold
818
– – ﹤0.01% 3312
2021
Q2 		$24K Buy
818
+179
+28% +$5.59K ﹤0.01% 3234
2021
Q1 		$21K Hold
639
– – ﹤0.01% 3118
2020
Q4 		$27K Buy
+639
New +$18.2K ﹤0.01% 2981

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Legal & General Group's TARS Position: Q2 2026 in Review

Legal & General Group increased its Tarsus Pharmaceuticals (TARS) stake by 11% in Q2 2026, buying an estimated $182K and bringing the position to 27,743 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

Legal & General Group first reported a position in TARS in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.55M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Legal & General Group held 27,743 shares of Tarsus Pharmaceuticals worth $1.75M as of Q2 2026.
  • Legal & General Group bought 2,847 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $182K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2011 holding.
  • Legal & General Group first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Legal & General Group's Tarsus Pharmaceuticals position peaked at $2.55M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.